• Profile
Close

Systemic safety of liposomal bupicivaine in simultaneous bilateral total knee arthroplasty

Journal of Arthroplasty Aug 24, 2017

Springer BD et al. – This prospective study evaluated the systemic safety profile and pharmacokinetics of full–dose intraoperative periarticular injection (PAI) liposomal bupivicaine in patients undergoing bilateral simultaneous TKA. Full–dose PAI with liposomal bupivicaine was safe with systemic bupivicaine levels well below reported cardiac and neurotoxic levels.

Methods

  • Blood samples were collected from 15 patients at predefined intervals until discharge and no exogenous bupivicaine was administered.
  • Pharmacokinetic evaluations were subsequently performed and compared with bupivicaine toxicity levels.
  • Adverse events related to anesthetic toxicity (cardiac and neurologic) were monitored in these patients.

Results

  • Mean peak level (Cmax) was 0.8 µg/mL.
  • All patients were well below the reported systemic cardiac and toxicity levels of 2 to 4 µg/mL.
  • None of the patients reported cardiac and neurotoxic events.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay